CHINA HEALTH GRP HD-10
Research CHINA HEALTH GRP HD-10 (VNL1) on Bullrun: market cap EUR 1.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVNL1
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 1.11M
- Financial periodFY2025
- RevenueCNY 28.56M
- Revenue growth8.0%
- Net income-CNY 14.96M
- Free cash flowCNY 7.58M
- Gross margin57.4%
Valuation Snapshot
latest market cap is EUR 1.11M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 28.56M | -CNY 14.96M | CNY 7.58M | 57.4% | n/a | CNY 21.82M | n/a | CNY 55.39M |
| FY2024 | CNY 26.45M | CNY 0 | CNY 8.52M | 38.1% | -0.01 | CNY 14.19M | n/a | CNY 70.35M |
| FY2023 | CNY 21.43M | -CNY 58.01M | -CNY 4.88M | 38.3% | -0.06 | CNY 4.14M | n/a | CNY 84.82M |
| FY2022 | CNY 13.09M | -CNY 15.83M | -CNY 5.16M | 43.9% | -0.02 | CNY 4.06M | n/a | CNY 142.32M |
| FY2021 | CNY 83.60M | CNY 36.33M | -CNY 10.28M | 76.4% | 0.04 | CNY 11.36M | CNY 0 | CNY 155.57M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 1.11M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About CHINA HEALTH GRP HD-10
China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CHINA HEALTH GRP HD-10's market cap?
CHINA HEALTH GRP HD-10's market capitalization is EUR 1.11M.
What does CHINA HEALTH GRP HD-10 do?
China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.